\-\ Texto\\:\\ \ \(0\)\
\-\ emg\\ positive\\ for\\ motor\\ neuron\\ disease\\.\\ \\ elevated\\ csf\\ protein\\.\ \(0\)\
\-\ steroids\ \(152\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ intensity\\ changes\\ in\\ corticospinal\\ tracts\\ in\\ brain\\ bilaterally\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mild\\ cervical\\ spinal\\ cord\\ atrophy\\ with\\ absence\\ of\\ normal\\ cervical\\ spinal\\ cord\\ enlargement\\.\ \(0\)\
\-\ als\\,\\ amyotrophic\\ \\ lateral\\ \\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ als\\ \\(amyotrophic\\ lateral\\ sclerosis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ adem\ \(0\)\
\-\ \\â\\€\\¢\\ lyme\\ disease\ \(0\)\
\-\ 57\\ year\\ old\\ woman\\ with\\ 6\\ month\\ history\\ of\\ progressive\\ weakness\\ and\\ muscle\\ atrophy\\.\\ \\ bowel\\ and\\ bladder\\ incontinence\\ noted\\ more\\ recently\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ als\\:\\ 0\\.3903810641208011\ \(0\)\
\-\ amyotrophic\\:\\ 0\\.3800468408571403\ \(0\)\
\-\ sclerosis\\:\\ 0\\.282255002755115\ \(0\)\
\-\ atrophy\\:\\ 0\\.24993779436928124\ \(0\)\
\-\ cord\\:\\ 0\\.19582648536266548\ \(0\)\
\-\ cervical\\:\\ 0\\.18921076464785513\ \(0\)\
\-\ spinal\\:\\ 0\\.1875856155838988\ \(0\)\
\-\ corticospinal\\:\\ 0\\.18223206998445474\ \(0\)\
\-\ neuron\\:\\ 0\\.16618155524563302\ \(0\)\
\-\ tracts\\:\\ 0\\.15468606369037774\ \(0\)\
\-\ lyme\\:\\ 0\\.1449639288749809\ \(0\)\
\-\ adem\\:\\ 0\\.14187187621210504\ \(0\)\
\-\ emg\\:\\ 0\\.1396648738775168\ \(0\)\
\-\ incontinence\\:\\ 0\\.1396648738775168\ \(0\)\
\-\ lateral\\:\\ 0\\.13110696855438236\ \(0\)\
\-\ 57\\:\\ 0\\.1246915765285067\ \(0\)\
\-\ protein\\:\\ 0\\.12258503421273434\ \(0\)\
\-\ steroids\\:\\ 0\\.11604965975058897\ \(0\)\
\-\ recently\\:\\ 0\\.1153026272890238\ \(0\)\
\-\ disease\\:\\ 0\\.11089357879803398\ \(0\)\
\-\ absence\\:\\ 0\\.10530904845075914\ \(0\)\
\-\ motor\\:\\ 0\\.1050715489532221\ \(0\)\
\-\ csf\\:\\ 0\\.10437332526112267\ \(0\)\
\-\ bladder\\:\\ 0\\.10250222724671508\ \(0\)\
\-\ enlargement\\:\\ 0\\.10126694782326635\ \(0\)\
\-\ progressive\\:\\ 0\\.10116692175836804\ \(0\)\
\-\ weakness\\:\\ 0\\.09640253328629304\ \(0\)\
\-\ intensity\\:\\ 0\\.0937928077919494\ \(0\)\
\-\ muscle\\:\\ 0\\.0937928077919494\ \(0\)\
\-\ elevated\\:\\ 0\\.09004767423131792\ \(0\)\
\-\ bilaterally\\:\\ 0\\.08809467076539963\ \(0\)\
\-\ positive\\:\\ 0\\.08704068293582144\ \(0\)\
\-\ bowel\\:\\ 0\\.08476967971553967\ \(0\)\
\-\ brain\\:\\ 0\\.08234470556631965\ \(0\)\
\-\ month\\:\\ 0\\.08035201854747133\ \(0\)\
\-\ changes\\:\\ 0\\.07982983167639526\ \(0\)\
\-\ high\\:\\ 0\\.07507143662479421\ \(0\)\
\-\ signal\\:\\ 0\\.07487820047127727\ \(0\)\
\-\ mild\\:\\ 0\\.07487820047127727\ \(0\)\
\-\ more\\:\\ 0\\.07253166872822273\ \(0\)\
\-\ noted\\:\\ 0\\.07003405081134186\ \(0\)\
\-\ woman\\:\\ 0\\.06879302787193767\ \(0\)\
\-\ in\\:\\ 0\\.06571952871917106\ \(0\)\
\-\ multiple\\:\\ 0\\.0646082102530133\ \(0\)\
\-\ and\\:\\ 0\\.0545896610437767\ \(0\)\
\-\ normal\\:\\ 0\\.05393155850183526\ \(0\)\
\-\ with\\:\\ 0\\.05172983997158466\ \(0\)\
\-\ of\\:\\ 0\\.05169894986136168\ \(0\)\
\-\ history\\:\\ 0\\.05046611774175785\ \(0\)\
\-\ year\\:\\ 0\\.040707610737971675\ \(0\)\
\-\ for\\:\\ 0\\.04003553740810624\ \(0\)\
\-\ old\\:\\ 0\\.03909339759760729\ \(0\)\
